This preplanned interim analysis of a single-arm clinical trial evaluates the efficacy and safety of avelumab as first-line treatment for patients with distant metastatic Merkel cell carcinoma.
from Cancer via ola Kala on Inoreader http://ift.tt/2FUC9Q6
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου